Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jared C Foster

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of the National Cancer Institute|March 21, 2023
Design of phase II oncology trials evaluating combinations of experimental agentsElad Sharon, Jared C Foster
Statistics in Medicine|May 8, 2013
Variable selection in monotone single-index models via the adaptive LASSOJared C Foster, Jeremy M G Taylor, Bin Nan
Biometrics|September 18, 2014
Reader reaction to "a robust method for estimating optimal treatment regimes" by Zhang et al. (2012)Jeremy M G Taylor, Wenting Cheng, Jared C Foster
Statistics in Medicine|August 5, 2011
Subgroup identification from randomized clinical trial dataJared C Foster, Jeremy M G Taylor, Stephen J Ruberg
Journal of the Royal Statistical Society. Series A, (Statistics in Society)|February 28, 2017
Identifying subgroups of enhanced predictive accuracy from longitudinal biomarker data using tree-based approaches: applications to fetal growthJared C Foster, Danping Liu, Paul S Albert, et al.
Journal of the National Cancer Institute|September 24, 2019
Single-Arm Phase II Trials of Combination Therapies: A Review of the CTEP Experience 2008-2017Jared C Foster, Boris Freidlin, Charles A Kunos, et al.
Biostatistics (Oxford, England)|November 16, 2014
Simple subgroup approximations to optimal treatment regimes from randomized clinical trial dataJared C Foster, Jeremy M G Taylor, Niko Kaciroti, et al.
JNCI Cancer Spectrum|November 24, 2023
The potential to backfill in phase I trials: the National Cancer Institute's Cancer Therapy Evaluation Program experienceJared C Foster, Edward L Korn, Boris Freidlin, et al.
Statistics in Biosciences|September 9, 2016
Permutation Testing for Treatment-Covariate Interactions and Subgroup IdentificationJared C Foster, Bin Nan, Lei Shen, et al.
Oncology Nursing Forum|September 7, 2013
Outcomes evaluation of a weekly nurse practitioner-managed symptom management clinic for patients with head and neck cancer treated with chemoradiotherapyHeidi Mason, Mary Beth DeRubeis, Jared C Foster, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of the National Cancer Institute|March 21, 2023
Design of phase II oncology trials evaluating combinations of experimental agentsElad Sharon, Jared C Foster
Statistics in Medicine|May 8, 2013
Variable selection in monotone single-index models via the adaptive LASSOJared C Foster, Jeremy M G Taylor, Bin Nan
Biometrics|September 18, 2014
Reader reaction to "a robust method for estimating optimal treatment regimes" by Zhang et al. (2012)Jeremy M G Taylor, Wenting Cheng, Jared C Foster
Statistics in Medicine|August 5, 2011
Subgroup identification from randomized clinical trial dataJared C Foster, Jeremy M G Taylor, Stephen J Ruberg
Journal of the Royal Statistical Society. Series A, (Statistics in Society)|February 28, 2017
Identifying subgroups of enhanced predictive accuracy from longitudinal biomarker data using tree-based approaches: applications to fetal growthJared C Foster, Danping Liu, Paul S Albert, et al.
Journal of the National Cancer Institute|September 24, 2019
Single-Arm Phase II Trials of Combination Therapies: A Review of the CTEP Experience 2008-2017Jared C Foster, Boris Freidlin, Charles A Kunos, et al.
Biostatistics (Oxford, England)|November 16, 2014
Simple subgroup approximations to optimal treatment regimes from randomized clinical trial dataJared C Foster, Jeremy M G Taylor, Niko Kaciroti, et al.
JNCI Cancer Spectrum|November 24, 2023
The potential to backfill in phase I trials: the National Cancer Institute's Cancer Therapy Evaluation Program experienceJared C Foster, Edward L Korn, Boris Freidlin, et al.
Statistics in Biosciences|September 9, 2016
Permutation Testing for Treatment-Covariate Interactions and Subgroup IdentificationJared C Foster, Bin Nan, Lei Shen, et al.
Oncology Nursing Forum|September 7, 2013
Outcomes evaluation of a weekly nurse practitioner-managed symptom management clinic for patients with head and neck cancer treated with chemoradiotherapyHeidi Mason, Mary Beth DeRubeis, Jared C Foster, et al.
Pageof 3